D. Lyu

606 total citations
30 papers, 390 citations indexed

About

D. Lyu is a scholar working on Surgery, Transplantation and Pulmonary and Respiratory Medicine. According to data from OpenAlex, D. Lyu has authored 30 papers receiving a total of 390 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Surgery, 11 papers in Transplantation and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in D. Lyu's work include Transplantation: Methods and Outcomes (24 papers), Renal Transplantation Outcomes and Treatments (10 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers). D. Lyu is often cited by papers focused on Transplantation: Methods and Outcomes (24 papers), Renal Transplantation Outcomes and Treatments (10 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (7 papers). D. Lyu collaborates with scholars based in United States, Australia and Canada. D. Lyu's co-authors include Martin R. Zamora, Jules Lin, Adriana Weinberg, Andrew L. Valesano, Rommel Sagana, Paul Lephart, Adam S. Lauring, Emily Stoneman, Joshua G. Petrie and Daniel Kaul and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

D. Lyu

27 papers receiving 389 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Lyu United States 10 228 127 94 80 70 30 390
Diana A. van Kessel Netherlands 13 197 0.9× 79 0.6× 49 0.5× 83 1.0× 91 1.3× 28 349
Hilary Robbins United States 11 214 0.9× 63 0.5× 30 0.3× 84 1.1× 97 1.4× 31 447
Sofya Tokman United States 10 137 0.6× 175 1.4× 57 0.6× 110 1.4× 30 0.4× 44 390
Dallas Dunn United States 11 148 0.6× 99 0.8× 49 0.5× 30 0.4× 140 2.0× 32 348
Michael Musk Australia 12 252 1.1× 159 1.3× 70 0.7× 174 2.2× 54 0.8× 24 477
A. Moreno Elola-Olaso Spain 12 358 1.6× 82 0.6× 19 0.2× 63 0.8× 104 1.5× 21 518
Jana Malušková Czechia 14 235 1.0× 59 0.5× 21 0.2× 58 0.7× 176 2.5× 40 532
Vincenzo Buscemi Italy 12 208 0.9× 99 0.8× 30 0.3× 108 1.4× 16 0.2× 23 368
Marcia M. L. Kho Netherlands 15 140 0.6× 115 0.9× 66 0.7× 43 0.5× 293 4.2× 44 566
K. Raza United States 8 242 1.1× 149 1.2× 51 0.5× 46 0.6× 156 2.2× 16 376

Countries citing papers authored by D. Lyu

Since Specialization
Citations

This map shows the geographic impact of D. Lyu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Lyu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Lyu more than expected).

Fields of papers citing papers by D. Lyu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Lyu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Lyu. The network helps show where D. Lyu may publish in the future.

Co-authorship network of co-authors of D. Lyu

This figure shows the co-authorship network connecting the top 25 collaborators of D. Lyu. A scholar is included among the top collaborators of D. Lyu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Lyu. D. Lyu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Williams, Jonathan, John M. Trahanas, Jacob A. Klapper, et al.. (2025). Use of Normothermic Regional Perfusion in Circulatory Death Donors for Lung Transplantation in the United States. Clinical Transplantation. 39(3). e70135–e70135. 2 indexed citations
4.
Combs, M.P., et al.. (2024). Incidence and Risk Factors of Venous Thromboembolism in Lung Transplant Recipients. The Journal of Heart and Lung Transplantation. 43(4). S475–S475. 1 indexed citations
5.
Combs, M.P., Karolin Walter, Elizabeth A. Belloli, et al.. (2024). Evaluation of Use of Tacrolimus vs. Cyclosporine on CLAD Incidence and Allograft Survival in the ISHLT Registry. The Journal of Heart and Lung Transplantation. 43(4). S297–S298. 1 indexed citations
6.
Thumma, Jyothi R., Valeria S.M. Valbuena, J. Stewart, et al.. (2023). The intersection of race and ethnicity, gender, and primary diagnosis on lung transplantation outcomes. The Journal of Heart and Lung Transplantation. 42(7). 985–992. 2 indexed citations
7.
Lyu, D., et al.. (2023). Lung transplantation for lung cancer: A systematic review of the literature. The Journal of Heart and Lung Transplantation. 42(10). 1425–1436. 4 indexed citations
8.
Aoki, Yoshiro, Natalie Walker, Keizo Misumi, et al.. (2022). The mitigating effect of exogenous carbon monoxide on chronic allograft rejection and fibrosis post-lung transplantation. The Journal of Heart and Lung Transplantation. 42(3). 317–326. 1 indexed citations
9.
Wakeam, Elliot, Jyothi R. Thumma, Andrew C. Chang, et al.. (2022). One-Year Mortality Is Not a Reliable Indicator of Lung Transplant Center Performance. The Annals of Thoracic Surgery. 114(1). 225–232. 4 indexed citations
10.
Belloli, Elizabeth A., Tian Gu, Yizhuo Wang, et al.. (2021). Radiographic Graft Surveillance in Lung Transplantation: Prognostic Role of Parametric Response Mapping. American Journal of Respiratory and Critical Care Medicine. 204(8). 967–976. 12 indexed citations
11.
Combs, M.P., Meng Xia, David Wheeler, et al.. (2020). Fibroproliferation in chronic lung allograft dysfunction: Association of mesenchymal cells in bronchoalveolar lavage with phenotypes and survival. The Journal of Heart and Lung Transplantation. 39(8). 815–823. 5 indexed citations
12.
Aversa, Meghan, D.R. Darley, A. Hirji, et al.. (2020). Approaches to the Management of Sensitized Lung Transplant Candidates: Findings from an International Survey. The Journal of Heart and Lung Transplantation. 39(4). S315–S315. 12 indexed citations
14.
Welsh, Carolyn H., Tisha S. Wang, D. Lyu, et al.. (2015). An International ISHLT/ATS/ERS Clinical Practice Guideline: Summary for Clinicians. Bronchiolitis Obliterans Syndrome Complicating Lung Transplantation. Annals of the American Thoracic Society. 12(1). 118–119. 19 indexed citations
15.
Lyu, D., et al.. (2012). Late-Onset Cytomegalovirus (CMV) in Lung Transplant Recipients: Can CMV Serostatus Guide the Duration of Prophylaxis?. American Journal of Transplantation. 13(2). 376–382. 32 indexed citations
16.
Weinberg, Adriana, et al.. (2010). Incidence and morbidity of human metapneumovirus and other community-acquired respiratory viruses in lung transplant recipients. Transplant Infectious Disease. 12(4). 330–335. 47 indexed citations
17.
Lyu, D. & Martin R. Zamora. (2009). Medical Complications of Lung Transplantation. Proceedings of the American Thoracic Society. 6(1). 101–107. 69 indexed citations
18.
Reece, T. Brett, John D. Mitchell, Martin R. Zamora, et al.. (2008). Native lung volume reduction surgery relieves functional graft compression after single-lung transplantation for chronic obstructive pulmonary disease. Journal of Thoracic and Cardiovascular Surgery. 135(4). 931–937. 15 indexed citations
19.
Freire-de-Lima, Célio Geraldo, William J. Janssen, Konosuke Morimoto, et al.. (2006). Oxidants Selectively Reverse TGF-β Suppression of Proinflammatory Mediator Production. The Journal of Immunology. 176(2). 1209–1217. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026